Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of AoAA11M: a new copper-dependent lytic polysaccharide monooxygenase for oxidative chitin degradation.

Carbohydrate research·2026
Same author

Discovering Serum Stable Protein-Protein Interaction Inhibitors with N‑Terminus-Capped Bicyclic Phage Libraries.

JACS Au·2026
Same author

Lan enzyme-free construction of lanthionine-bridged macrocyclic phage libraries.

Chemical science·2026
Same author

Enhancing composting efficiency and heavy metal stabilization through thermophilic microbial inoculation.

Environmental technology·2025
Same author

Optimization technique for transmissive THz-TDS detection in non-destructive testing conventional environments based on filtering and a peak attention network.

Applied optics·2025
Same author

Unveiling the Relationship Between L2 Utterance Fluency and Perceived Fluency in Monologic and Dialogic Speaking.

Language and speech·2025
Same journal

Overview of Immunotherapy in Lung Cancer: Present Landscape.

Current topics in medicinal chemistry·2026
Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026
Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026
Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026
Same journal

Inhibitory Effects of Flavonoids from the Stems and Leaves of Scutellaria baicalensis Georgi on Oligodendrocyte Pyroptosis Induced by Aβ1-42.

Current topics in medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Apr 8, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K

Recent Advances in Peptide Immunomodulators.

Breanna L Zerfas, Jianmin Gao1

  • 1Boston College Department of Chemistry, 2609 Beacon St., Chestnut Hill, MA 02467, USA. jianmin.gao@bc.edu.

Current Topics in Medicinal Chemistry
|July 2, 2015
PubMed
Summary
This summary is machine-generated.

New therapeutic agents are crucial due to rising antibiotic resistance. Host-defense peptides (HDPs) and their synthetic mimics offer promising alternatives with unique mechanisms and fewer side effects than traditional antibiotics.

More Related Videos

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

10.0K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K

Related Experiment Videos

Last Updated: Apr 8, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

10.0K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K

Area of Science:

  • Biochemistry
  • Microbiology
  • Drug Discovery

Background:

  • Rising antibiotic resistance necessitates novel therapeutic strategies.
  • Host-defense peptides (HDPs) present an alternative to conventional antibiotics, targeting host mechanisms.
  • HDPs offer advantages like reduced resistance development and broad-spectrum activity but face challenges such as degradation and toxicity.

Purpose of the Study:

  • To review the progression of research into HDPs and their synthetic analogs.
  • To explore the design of novel therapeutic agents inspired by natural HDPs.
  • To highlight the evolution from natural HDPs to peptidomimetics and non-peptide synthetic constructs.

Main Methods:

  • Analysis of prominent natural Host-Defense Peptides (HDPs).
  • Examination of peptidomimetic structures designed to emulate HDP functions.
  • Review of synthetic constructs mimicking HDP behavior without peptide similarity.

Main Results:

  • Natural HDPs provide a foundation for understanding antimicrobial mechanisms.
  • Peptidomimetics and synthetic constructs offer potential solutions to the limitations of natural HDPs.
  • Research has advanced to sophisticated design platforms for novel antimicrobial agents.

Conclusions:

  • The study of HDPs has paved the way for innovative antimicrobial drug design.
  • Synthetic analogs and peptidomimetics show promise in overcoming natural peptide limitations.
  • Continued research in this area is vital for addressing the challenge of antibiotic resistance.